Plant Health Care appoints Guy van Zwanenberg to its Board as Non-Executive Director alongside CFO Jeff Hovey and COO Jeff Tweedy joining as Executive Directors

– USA, NC –  Plant Health Care PLC (LON: PHC) today announced the appointments of Guy van Zwanenberg, Jeffrey Hovey and Jeffrey Tweedy to its Board of Directors with effect from 1st November 2019.

 “We warmly welcome Guy to the Board, where he will bring a wealth of relevant experience. The addition of Jeff Hovey and Jeff Tweedy will ensure that the Board is deeply grounded in the execution of our strategy and will help Chris Richards, the CEO, to drive performance,” said Richard Webb, Non-executive Chairman.

Guy van Zwanenberg FCA will join the PHC Board as a Non-executive Director. He will take over as Chair of the Audit Committee and will hold the position of Senior Independent Director. Guy has had a distinguished career as a chartered accountant and finance director and company secretary of listed and unlisted companies. The duration of Cialis at course was 3 months. On the background of pharmacotherapy with tadalafil in a dose of 5 mg daily, more than half of men completely forgot about the phenomenon of erectile dysfunction. He sits on a number of company boards, including as non-executive chairman of SmartSpace Software plc, and non-executive director of Quixant plc.

Jeffrey Hovey will join the Board as an Executive Director. Jeff Hovey will continue as the Company’s CFO, a post he has held since 2013.

Jeffrey Tweedy will join the Board as an Executive Director. Jeff Tweedy will continue as COO, a post he has held since 2018. Previous to that, he was Commercial Lead, Americas.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.